AU2002341555A1 - Levothyroxine pharmaceutical compositions, methods of making and methods of administration - Google Patents

Levothyroxine pharmaceutical compositions, methods of making and methods of administration

Info

Publication number
AU2002341555A1
AU2002341555A1 AU2002341555A AU2002341555A AU2002341555A1 AU 2002341555 A1 AU2002341555 A1 AU 2002341555A1 AU 2002341555 A AU2002341555 A AU 2002341555A AU 2002341555 A AU2002341555 A AU 2002341555A AU 2002341555 A1 AU2002341555 A1 AU 2002341555A1
Authority
AU
Australia
Prior art keywords
methods
administration
making
pharmaceutical compositions
levothyroxine pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002341555A
Inventor
Phillip A. Dimenna
Andrew G. Franz
Rocco L. Gemma
Elaine A. Strauss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
King Pharmaceuticals Inc
Original Assignee
King Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King Pharmaceuticals Inc filed Critical King Pharmaceuticals Inc
Publication of AU2002341555A1 publication Critical patent/AU2002341555A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
AU2002341555A 2001-08-14 2002-08-14 Levothyroxine pharmaceutical compositions, methods of making and methods of administration Abandoned AU2002341555A1 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US31211401P 2001-08-14 2001-08-14
US31228701P 2001-08-14 2001-08-14
US31248301P 2001-08-14 2001-08-14
US31218401P 2001-08-14 2001-08-14
US31227301P 2001-08-14 2001-08-14
US31211301P 2001-08-14 2001-08-14
US60/312,184 2001-08-14
US60/312,287 2001-08-14
US60/312,273 2001-08-14
US60/312,114 2001-08-14
US60/312,113 2001-08-14
US60/312,483 2001-08-15
PCT/US2002/025854 WO2003061557A2 (en) 2001-08-14 2002-08-14 Levothyroxine pharmaceutical compositions, methods of making and methods of administration

Publications (1)

Publication Number Publication Date
AU2002341555A1 true AU2002341555A1 (en) 2003-09-02

Family

ID=27617967

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002341555A Abandoned AU2002341555A1 (en) 2001-08-14 2002-08-14 Levothyroxine pharmaceutical compositions, methods of making and methods of administration

Country Status (2)

Country Link
AU (1) AU2002341555A1 (en)
WO (2) WO2003028624A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645526B2 (en) 2001-11-13 2003-11-11 Mylan Pharmaceuticals, Inc. Storage stable thyroxine active drug formulations and methods for their production
US20030099699A1 (en) 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
CA2546601A1 (en) 2003-11-19 2005-06-09 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
EP1898926A2 (en) 2005-05-26 2008-03-19 Metabasis Therapeutics, Inc. Thyromimetics for the treatment of fatty liver diseases
CA3044059A1 (en) 2016-11-21 2018-05-24 Viking Therapeutics, Inc. Method of treating glycogen storage disease
EA201992703A1 (en) 2017-06-05 2020-04-15 Вайкинг Терапьютикс, Инк. COMPOSITIONS FOR TREATING FIBROSIS
CA3094167A1 (en) 2018-03-22 2019-09-26 Viking Therapeutics, Inc. Crystalline forms and methods of producing crystalline forms of a compound
CN115175663A (en) * 2020-01-13 2022-10-11 安尼尔复合产品资源有限公司 Sustained release compositions comprising liothyronine
US11964048B2 (en) 2020-12-18 2024-04-23 Amneal Complex Products Research Llc Sustained release compositions comprising liothyronine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
EP0861073B1 (en) * 1995-11-14 2004-07-28 Abbott GmbH & Co. KG Stabilized thyroid hormone preparations and methods of making same
WO1999063969A1 (en) * 1998-06-08 1999-12-16 Groenewoud Pieter J Stabilized thyroxine medications

Also Published As

Publication number Publication date
WO2003061557A3 (en) 2003-11-06
WO2003061557A2 (en) 2003-07-31
WO2003028624A3 (en) 2003-11-06
WO2003028624A2 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
AU2001237525A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
AU2001237526A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
AU2002309172A1 (en) Pharmaceutical compositions containing polymer and drug assemblies
AU2003230700A1 (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
AU2003240947A1 (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
AU2002324914A1 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
MXPA02003596A (en) Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation.
AU2002313236A1 (en) Medicinal compositions
AU777185C (en) Pharmaceutical form of administration for peptides, methods for its production and use
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
AU2002341555A1 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
AU2002330233A1 (en) Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
IL159219A0 (en) Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them
AU2002360117A1 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
HUP0401713A3 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
AU2002244865A1 (en) Pharmaceutical composition of ibuprofen
AU2002334123A1 (en) Anaesthetic compositions and method for their administration
AU2002308649A1 (en) Compositions and methods for enhancing drug delivery
AU2003295713A1 (en) Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions
AU2001288695A1 (en) Flavoring systems for pharmaceutical compositions and methods of making such compositions
HUP0304065A2 (en) Novel 5-thio-betha-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and use thereof
AU2002354460A1 (en) Medicinal composition
AU2001250625A1 (en) 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them
AUPR529701A0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase